bit.bio Launches New Custom Disease Model Cells Offering, Advancing Disease Research and Drug Discovery
SAN FRANCISCO & CAMBRIDGE, England--(BUSINESS WIRE)-- #Celltherapy--bit.bio, the cell coding company today launches its new Custom ioDisease Model Cells offering. This offering allows scientists to commission their disease-relevant mutation of interest in bit.bio's human induced pluripotent stem cell (iPSC)-derived cells powered by opti-ox technology. The disease-relevant mutation is engineered into...
